Qinhong Luo

发表

Diversity-Oriented Synthesis of ERα Modulators via Mitsunobu Macrocyclization.

Feng Yin, Zigang Li, Jinqiang Zhang, 2022, Organic letters.

Identification of α‐Mangostin as an Agonist of Human STING

J. Quan, Qinkai Li, Zhen Sun, 2018, ChemMedChem.

YT521-B homology domain family proteins as N6-methyladenosine readers in tumors

Junrong Huang, Duo Zheng, Qinhong Luo, 2022, Frontiers in Genetics.

Vanishing twin after 12 gestational weeks is associated with adverse perinatal outcomes in in vitro fertilization cycles

Jun Liu, Chao Li, Qinhong Luo, 2022, Clinical and Experimental Obstetrics & Gynecology.

S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.

J. Quan, Yuchen Yang, Zhenghua Wang, 2022, European journal of medicinal chemistry.

STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity.

J. Quan, Qinkai Li, Wen-xian Zheng, 2019, Cancer letters.

Genetically-encoded degraders as versatile modulators of intracellular therapeutic targets

Jinpeng Wang, Licheng Tu, Qinhong Luo, 2023, Current Opinion in Biomedical Engineering.

Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach.

F. Yin, Zigang Li, Zhanfeng Hou, 2023, Journal of the American Chemical Society.

Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach.

F. Yin, Zigang Li, Zhanfeng Hou, 2023, Journal of the American Chemical Society.

Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation

Daoyuan Chen, Youqiao Wang, Qinhong Luo, 2023, Nature communications.